SCIENTIFIC HUB

Araştırmanın izini sürün.

SCIENTIFIC LITERATURE · MED

Sistemik inflamasyon yanıt indeksi ve Parkinson hastalığı riski: Kesitsel bir çalışma.

Systemic inflammation response index and Parkinson's disease risk: A cross-sectional study.

Makine çevirisi · Editoryal inceleme bekliyor

Medicine (Baltimore) · 2026-01-01

DOI: 10.1097/md.0000000000047182PMID: 41578528

Open accessresearch-article; Journal Article; Observational StudyKaynağa git ↗

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

Parkinson's disease (PD) is a highly prevalent neurodegenerative disorder, and inflammation plays a critical role in its pathogenesis. The systemic inflammation response index (SIRI) reflects the overall inflammatory status and has been associated with the development of various diseases. This study aims to investigate the association between the SIRI and PD. Data was obtained from the National Health and Nutrition Examination Survey from 2003 to 2020. A total of 29,022 participants aged ≥40 years were included, of whom 275 were diagnosed with PD. Weighted multivariable logistic regression models were used to evaluate the association between the SIRI and PD, with progressive adjustments for demographic and clinical covariates. Restricted cubic spline regression was used to assess potential nonlinearity, whereas subgroup analyses were used to examine effect modifications. The predictive performance of the SIRI for PD was evaluated via receiver operating characteristic curves. PD patients were older and had higher prevalence of hypertension, diabetes, body mass index, and SIRI level compared with non-PD participants (all P < .05). In unadjusted analysis, each unit increase in SIRI was associated with higher odds of PD (odds ratio = 1.208, 95% confidence interval: 1.112-1.313, P < .001). The association remained significant after full adjustment (odds ratio = 1.162, 95% confidence interval: 1.051-1.285, P = .004). Restricted cubic spline analysis revealed a positive association between the SIRI and PD prevalence (P-overall < .001), with evidence of a nonlinear trend (P-nonlinear = .047). Subgroup analyses showed consistent results across age, sex, race, education level, body mass index, hypertension, diabetes, and smoke, with no significant interactions. The predictive ability of the SIRI for PD was modest, with an area under the receiver operating characteristic curve (area under the curve) of 0.579. Our findings demonstrate a significant dose-response association between the SIRI and PD. This highlights the potential utility of the SIRI as a predictive biomarker, which may be incorporated into screening frameworks to facilitate early detection and preventive interventions.

Bilimsel değerlendirme

01

Araştırma sorusu

Sorunun kapsamı orijinal çalışma üzerinden değerlendirilir.

02

Yöntem ve örneklem

Çalışma tasarımı ve örneklem için kaynak makaleyi kontrol edin.

03

Temel bulgular

Bu kayıt için editoryal olarak onaylanmış bulgu özeti henüz yayımlanmadı.

04

Sınırlılıklar

Sonuçların genellenebilirliği, yanlılık ve klinik anlamı ayrıca incelenmelidir.

Bibliyografik veriden yöntem, örneklem veya klinik sonuç çıkarımı yapılmaz.